These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38859626)

  • 1. Clinical versus fixed warfarin dosing and the impact on quality of anticoagulation (The ClinFix trial).
    Fahmi AM; El Bardissy A; Saad MO; Elshafei MN; Bader L; Mahfouz A; Kasem M; Abdelsamad O; Elzouki A; Aquilante CL; Mraiche F; Soaly E; El Madhoun I; Asaad N; Arabi A; Alhmoud E; Elewa H
    Clin Transl Sci; 2024 Jun; 17(6):e13797. PubMed ID: 38859626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Inpatient Versus Outpatient Initiation on Early Warfarin Dosing.
    Kasner SE; Wang L; French B; Messe SR; Horenstein R; Mohler ER; Muldowney JA; Ellenberg J; Kimmel SE
    Am J Cardiovasc Drugs; 2015 Aug; 15(4):267-74. PubMed ID: 26037731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
    Meijer K; Kim YK; Carter D; Schulman S
    Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial.
    Marcatto LR; Sacilotto L; Bueno CT; Facin M; Strunz CM; Darrieux FC; Scanavacca MI; Krieger JE; Pereira AC; Santos PC
    BMC Cardiovasc Disord; 2016 Nov; 16(1):224. PubMed ID: 27855643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic analysis and comparison of warfarin initiation strategies.
    French B; Wang L; Gage BF; Horenstein RB; Limdi NA; Kimmel SE
    Pharmacogenet Genomics; 2016 Oct; 26(10):445-52. PubMed ID: 27383664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic.
    Cao H; Wu J; Zhang J
    Int J Clin Pharm; 2018 Oct; 40(5):1072-1077. PubMed ID: 29956134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of pharmacogenetic algorithms and warfarin dosing table in Egyptian patients.
    Bazan NS; Sabry NA; Rizk A; Mokhtar S; Badary O
    Int J Clin Pharm; 2012 Dec; 34(6):837-44. PubMed ID: 22851439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-based warfarin dosing compared with standard of care practices in an orthopedic surgery population: a prospective, parallel cohort study.
    McMillin GA; Melis R; Wilson A; Strong MB; Wanner NA; Vinik RG; Peters CL; Pendleton RC
    Ther Drug Monit; 2010 Jun; 32(3):338-45. PubMed ID: 20386359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy.
    Nieuwlaat R; Hubers LM; Spyropoulos AC; Eikelboom JW; Connolly BJ; Van Spall HG; Schulze KM; Cuddy SM; Stehouwer AC; Schulman S; Connolly SJ
    Thromb Haemost; 2012 Dec; 108(6):1228-35. PubMed ID: 23015161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of preemptive warfarin dose reduction on anticoagulation after initiation of trimethoprim-sulfamethoxazole or levofloxacin.
    Ahmed A; Stephens JC; Kaus CA; Fay WP
    J Thromb Thrombolysis; 2008 Aug; 26(1):44-8. PubMed ID: 17985084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended International Normalized Ratio testing intervals for warfarin-treated patients.
    Barnes GD; Kong X; Cole D; Haymart B; Kline-Rogers E; Almany S; Dahu M; Ekola M; Kaatz S; Kozlowski J; Froehlich JB
    J Thromb Haemost; 2018 Jul; 16(7):1307-1312. PubMed ID: 29763979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.
    Stergiopoulos K; Brown DL
    JAMA Intern Med; 2014 Aug; 174(8):1330-8. PubMed ID: 24935087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial.
    Kimmel SE; French B; Anderson JL; Gage BF; Johnson JA; Rosenberg YD; Geller NL; Kasner SE; Eby CS; Joo J; Caldwell MD; Goldhaber SZ; Hart RG; Cifelli D; Madigan R; Brensinger CM; Goldberg S; Califf RM; Ellenberg JH
    Am Heart J; 2013 Sep; 166(3):435-41. PubMed ID: 24016491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation.
    Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A
    Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paper-based dosing algorithms for maintenance of warfarin anticoagulation.
    Wilson SE; Costantini L; Crowther MA
    J Thromb Thrombolysis; 2007 Jun; 23(3):195-8. PubMed ID: 17186393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study.
    Kim YK; Nieuwlaat R; Connolly SJ; Schulman S; Meijer K; Raju N; Kaatz S; Eikelboom JW
    J Thromb Haemost; 2010 Jan; 8(1):101-6. PubMed ID: 19840361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic.
    Shaw PB; Donovan JL; Tran MT; Lemon SC; Burgwinkle P; Gore J
    J Thromb Thrombolysis; 2010 Aug; 30(2):220-5. PubMed ID: 20204461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of warfarin dosing in the intensive care unit following the Fontan procedure.
    Thomas CA; Taylor K; Schamberger MS; Rotta AT
    Congenit Heart Dis; 2014; 9(4):361-5. PubMed ID: 25247218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic dosing of warfarin in the Han-Chinese population: a randomized trial.
    Wen MS; Chang KC; Lee TH; Chen YF; Hung KC; Chang YJ; Liou CW; Chen JJ; Chang CH; Wang CY; Jeng JS; Chuang HP; Chen YT; Chen CH; Wu JY; Chen YT; Lee MT
    Pharmacogenomics; 2017 Feb; 18(3):245-253. PubMed ID: 28112575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.